Larimar Therapeutics, Inc. · NASDAQ:LRMR
Janus Henderson Group PLC reported a 9.10% stake in Larimar Therapeutics, Inc. (Schedule 13G/A)
Event Mar 31, 2025 · Filed May 14, 2025
Janus Henderson Group PLC reported a 9.10% stake in Larimar Therapeutics, Inc., 3,356,076 shares, as a passive investor on Mar 31, 2025. Filed May 14, 2025 (Schedule 13G/A).
- Stake
- 9.10%
- Shares
- 3,356,076
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| JANUS HENDERSON GROUP PLC | 8.70% | 5,571,963 |
| Janus Henderson Biotech Innovation Master Fund Ltd | 9.10% | 3,356,076 |
Source
Related
- Larimar Therapeutics, Inc.
- Janus Henderson Group PLC
- Larimar Therapeutics, Inc. shareholders
- Schedule 13G/A · Janus Henderson Group PLC · Aug 14, 2025
- Schedule 13G/A · Janus Henderson Group PLC · Jan 8, 2025
- Form 4 · Harlow John B. Jr. · Oct 1, 2026
- Form 4 · Hamilton Thomas Edward · Jul 8, 2026
- Schedule 13G/A · Blue Owl Capital Holdings LP · May 14, 2026
- Schedule 13G/A · Millennium Management LLC · Apr 30, 2026
- Schedule 13D/A · Deerfield Management Company, L.P. · Mar 2, 2026